
Overview
Karen Fink, MD, PhD, is the Medical Director of Clinical Neuro-Oncology Research at Baylor University Medical Center. Dr. Fink leads our neuro-oncology team, heading the multi-disciplinary Baylor Scott and White Sammons Cancer Center brain tumor board and multiple clinical trials for patients with brain tumors. She has a long history of involvement in advanced clinical trials in collaboration with industry groups and with prominent neuro-oncology programs nationwide. Dr. Fink received her undergraduate degree in biochemistry from Washington University in St. Louis, Missouri. She then completed her MD and PhD at the Mayo Clinic in Rochester, Minnesota, where she investigated early cellular activation of cancer-causing genes in response to growth signals. Her Neurology residency and Neuro-oncology fellowship were accomplished at UT Southwestern Medical Center in Dallas. She stayed there after completing her training, becoming the Director of Clinical Neuro-Oncology. She moved to Baylor University Medical Center to found Neuro-Oncology Associates in 2006. At Baylor Scott & White, she continued to offer clinical trials as an investigator in the North American Brain Tumor Consortium, and later, the Brain Tumor trials Collaborative spearheaded at the National Institute of Health. She still works with pharmaceutical and device companies to offer advanced treatments for patients with brain tumors. Dr. Fink has participated in over 50 neuro-oncology clinical trials, been an author on over 50 peer reviewed publications, and over 80 abstracts covering various aspects of Neuro-Oncology research. She mentors Neurology Residents, Oncology fellows and medical students, instilling knowledge regarding the management of primary brain tumor patients and providing an example of compassionate and up-to-date clinical care. Dr. Fink has formally served as a member of the Corporate Compliance Committee and the Multidisciplinary Cancer Committee at Baylor Scott and White. She is a member of the Society for Neuro-Oncology and the American Society of Clinical Oncology. Dr. Fink specializes in the treatment of tumors in the brain, central nervous system, and peripheral nervous system. She collaborates with Neuro-Oncology clinicians and their medical teams in north and central Texas, and with Neurosurgeons, Radiation Oncologists, Medical Oncologists, Neuro-Radiologists and Palliative Care clinicians across the region to coordinate complete care for patients and their loved ones who are dealing with a brain tumor. Dr. Fink has been named one of Texas Monthly's Texas Super Doctors for over 10 years earning her a place on Texas Monthly's Hall of Fame list. Read more about Dr. Fink’s research publications on PubMed.gov.
Dr. Fink is highly rated in 16 conditions, according to our data. Her top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Brain Tumor.
Her clinical research consists of co-authoring 17 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3410 Worth St, Ste 820, Dallas, TX 75246
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
6 Clinical Trials
University Of Texas Southwestern Medical Center
Benjamin Greenberg is a Neurologist in Dallas, Texas. Dr. Greenberg is highly rated in 19 conditions, according to our data. His top areas of expertise are Transverse Myelitis, Optic Neuritis, Neuromyelitis Optica, and Multiple Sclerosis (MS).
Texas Neurology, P.A.
Dr. Schiffmann is a renowned expert on neurometabolic diseases. He earned his medical degree from the University of Liège, Belgium and a Master of Health Sciences in Clinical Research from Duke University. He is board-certified in Neurology with a Special Qualification in Child Neurology and is a Fellow of the American Academy of Neurology. Dr. Schiffmann was a lead researcher at the United States National Institutes of Health in Bethesda, Maryland for over 17 years (1991-2007) and then the Director of the Institute of Metabolic Disease at the Baylor Scott & White Research Institute in Dallas, Texas, 2008-2019. Dr. Schiffmann is a Professor in the Department of Internal Medicine, Texas Christian University and a Clinical Professor, Texas A&M University Medical School College of Medicine. He is also a Senior Vice President for Clinical Research at 4D Molecular Therapeutics. Dr. Schiffmann has been performing pre-clinical and clinical research on lysosomal storage diseases since 1991 with a special focus on the natural history, pathogenesis and therapy of Fabry disease, Gaucher disease and the leukodystrophies. One of his particular interests and areas of expertise is to address patients with undiagnosed neurological diseases. Dr. Schiffmann has published 276 peer-reviewed research articles and over 15 book chapters. Dr. Schiffmann is highly rated in 10 conditions, according to our data. His top areas of expertise are Gaucher Disease Type 3, Fabry Disease, Gaucher Disease, and Leukodystrophy.
Texas Scottish Rite Hospital For Children
Charuta Joshi is a Neurologist in Dallas, Texas. Dr. Joshi is highly rated in 28 conditions, according to our data. Her top areas of expertise are Epilepsy, Seizures, West Syndrome, Lennox-Gastaut Syndrome (LGS), and Deep Brain Stimulation.
Frequently Asked Questions about Dr. Karen L. Fink
How do I make an appointment with Dr. Karen L. Fink?
You can book an appointment with Dr. Karen L. Fink by calling their office at 214-820-8690. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Karen L. Fink a top-rated expert for Astrocytoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Karen L. Fink is classified as an Elite expert for Astrocytoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Karen L. Fink specialize in?
While Dr. Karen L. Fink is a Neurology, they have specific expertise in Astrocytoma, Glioblastoma, and Glioma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.
Does Dr. Karen L. Fink participate in research or clinical trials?
Yes. Dr. Karen L. Fink has published 17 articles and abstracts on conditions like Astrocytoma. You can view a list of Dr. Karen L. Fink's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Karen L. Fink accept my insurance?
Dr. Karen L. Fink accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 214-820-8690 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- AstrocytomaDr. Fink isElite. Learn about Astrocytoma.
- GlioblastomaDr. Fink isElite. Learn about Glioblastoma.
- GliomaDr. Fink isElite. Learn about Glioma.
- Distinguished
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Fink isDistinguished. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Brain TumorDr. Fink isDistinguished. Learn about Brain Tumor.
- Embryonal Tumor with Multilayered Rosettes
- EpendymomaDr. Fink isDistinguished. Learn about Ependymoma.
- Gliomatosis CerebriDr. Fink isDistinguished. Learn about Gliomatosis Cerebri.
- GliosarcomaDr. Fink isDistinguished. Learn about Gliosarcoma.
- Advanced
- MedulloblastomaDr. Fink isAdvanced. Learn about Medulloblastoma.
- Experienced
- Brain Stem CancerDr. Fink isExperienced. Learn about Brain Stem Cancer.
- Cerebral Ventricle CancerDr. Fink isExperienced. Learn about Cerebral Ventricle Cancer.
- Choroid Plexus PapillomaDr. Fink isExperienced. Learn about Choroid Plexus Papilloma.
- Dysembryoplastic Neuroepithelial Tumors (DNET)
- SubependymomaDr. Fink isExperienced. Learn about Subependymoma.
